Netherlands (NL)

Nonresonant Raman spectroscopy of isolated human retina samples complying with laser safety regulations for in vivo measurements (2019) Stiebing C, Schie IW, Knorr F, Schmitt M, Keijzer N, Kleemann R, Jahn IJ, et al. Journal article Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy (2019) Renner K, Bruss C, Schnell A, Koehl G, Becker HM, Fante M, Menevse AN, et al. Journal article Grand Research Challenges for Sustainable Industrial Biotechnology (2019) Straathof AJJ, Benjamin KR, Takors R, Wierckx N, Noorman HJ, Wahl SA Journal article, Review article CTCF variants in 31 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum (2019) Konrad E, Nardini N, Blyth M, Prescott K, Bouman AM, Brilstra EH, Caliebe A, et al. Conference contribution The impact of chloride secretion on the progression of polycystic kidney disease (2019) Kraus A, Faria D, Schley G, Schödel J, Grampp S, Peters DJ, Schreiber R, et al. Journal article Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on Ethylzingerone - 'Hydroxyethoxyphenyl Butanone' (HEPB) - Cosmetics Europe No P98-CAS No 569646-79-3-Submission II (eye irritation) (2019) Bernauer U, Bodin L, Chaudhry Q, Coenraads P, Dusinska M, Ezendam J, Gaffet E, et al. Journal article, Editorial Opinion of the Scientific Committee on consumer safety (SCCS) - Final opinion on the safety of fragrance ingredient Acetylated Vetiver Oil (AVO) - (Vetiveria zizanioides root extract acetylated) - Submission III (2019) Bernauer U, Bodin L, Chaudhry Q, Coenraads P, Dusinska M, Ezendam J, Gaffet E, et al. Journal article, Editorial Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study (2019) Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, et al. Conference contribution Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial (2019) Highland K, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, et al. Conference contribution Time to Flare in Patients with New-Onset versus Relapsing Giant Cell Arteritis Treated with Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results from a Randomized Controlled Phase 3 Trial (2019) Stone J, Spotswood H, Unizony S, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution